CD155 as a prognostic and predictive biomarker in acute myeloid leukemia

High expression of CD155 in adult patients with AML is associated with a lower CRc, shorter RFS, and OS. It could be included within the predictive and prognostic panels.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-05-24
DOI
https://doi.org/10.1007/s12672-025-02665-2
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD155 as a prognostic and predictive biomarker in acute myeloid leukemia

Nehal A. Rayan, Ashraf Zeidan Abdalla, Asmaa Mohamed Zahran, Salah Mabrouk Khallaf et al.
Discover Oncology
Acute Myeloid Leukemia Research
article

CD155 as a prognostic and predictive biomarker in acute myeloid leukemia

Nehal A. Rayan, Ashraf Zeidan Abdalla, Asmaa Mohamed Zahran, Salah Mabrouk Khallaf, Ahmed Refaat Abd Elzaher
article en

Abstract

High expression of CD155 in adult patients with AML is associated with a lower CRc, shorter RFS, and OS. It could be included within the predictive and prognostic panels.

Discover OncologyVol. 16(1)
Assiut University (EG)
Assiut University
Good health and well-being
Openalex Percentile: Top 86%
Acute Myeloid Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CD155 as a prognostic and predictive biomarker in acute myeloid leukemia — Nehal A. Rayan, Ashraf Zeidan Abdalla, et al. · Discover Oncology (2025) | TGRS Research Map | TGRS